Recent Finacing
Recent Raise
Otonomy is a clinical-stage biopharmaceutical company developing sustained-release, intratympanic-delivered therapeutics for middle and inner ear disorders, including antibiotics, steroids, and NMDA antagonists for otitis media, Meniere's, and tinnitus.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors